## SLB: SLB Limited - XLE: Energy

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 5.2% in lower entry zone (4.0-10.0%), top quartile (76th pct) cross-sectional ranking. Short-term MRS_5 (0.3%) confirms momentum alignment. Strong momentum (+2.3% 5-day acceleration). Outperforming sector by 5.3%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($36.68)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. SLB Signs Strategic Collaboration Agreement with Shell**
- Source: Insider Monkey | 20251215T150845 | Bullish | Relevance: 100%
- SLB N.V. (NYSE:SLB) has signed a strategic collaboration agreement with Shell plc (NYSE:SHEL) to develop AI-driven digital solutions aimed at boosting performance and upstream efficiency, leveraging SLB’s Lumi data and AI platform. This news comes as analysts raised price targets for SLB, citing a positive outlook for the energy sector. However, the article suggests that some AI stocks offer potentially higher returns and limited downside risk.

**2. SLB and Shell join forces to supercharge AI in upstream energy operations**
- Source: Indian Chemical News | 20251215T070831 | Bullish | Relevance: 100%
- SLB and Shell have announced a strategic collaboration to develop advanced digital and AI solutions for upstream energy operations. This partnership will leverage SLB’s Lumi data and AI platform to create agentic AI-powered tools, enhancing the capabilities of technical experts and decision-makers across subsurface, well construction, and production workflows. The initiative aims to boost performance, efficiency, and accelerate digital transformation for both companies and the broader industry.

**3. Caxton Associates LLP Makes New Investment in SLB Limited $SLB**
- Source: MarketBeat | 20251216T090854 | Somewhat-Bullish | Relevance: 100%
- Caxton Associates LLP recently acquired a new stake of 44,088 shares in SLB Limited (NYSE:SLB), valued at approximately $1.49 million, contributing to institutional investors owning around 81.99% of the company. SLB reported Q2 EPS of $0.69, beating estimates, and a revenue of $8.93 billion, while also declaring a quarterly dividend of $0.285. The stock, currently trading at $38.95, has an average analyst price target of $52.32, indicating a "Moderate Buy" rating despite recent insider share sales.

**4. Is SLB Offering Long Term Value After Its Digital and Low Carbon Expansion?**
- Source: Simply Wall Street | 20251216T012717 | Bullish | Relevance: 100%
- SLB appears to be undervalued based on its digital and low-carbon technology expansion, as indicated by both Discounted Cash Flow (DCF) and Price-to-Earnings (PE) analyses. The DCF model suggests a 57.0% discount compared to its intrinsic value, while its current PE ratio of 15.9x is below its proprietary "Fair Ratio" of 20.3x, implying potential undervaluation. Investors are encouraged to explore different perspectives on SLB's future using "Narratives" on Simply Wall St's community page.

**5. Lazard Asset Management LLC Buys 3,031,906 Shares of SLB Limited $SLB**
- Source: MarketBeat | 20251214T140845 | Bullish | Relevance: 100%
- Lazard Asset Management LLC significantly increased its stake in SLB Limited, purchasing over 3 million additional shares to bring its total holding to 6.78 million shares, valued at $229.47 million. This substantial investment follows SLB's recent earnings report, where the company beat EPS estimates but saw a slight revenue decline, and amidst declarations of a quarterly dividend. The article also highlights other institutional investor activity, insider trades, and various analyst ratings which currently average a "Moderate Buy" for SLB.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | UBS | $50 | $44 | +14% |
| 2025-12-11 | Citigroup | $53 | $47 | +13% |
| 2025-12-11 | TD Cowen | $57 | $56 | +2% |
| 2025-12-11 | Bernstein | $52 | $48 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | UBS | main | Buy |
| 2025-12-11 | Citigroup | main | Buy |
| 2025-12-11 | TD Cowen | main | Buy |
| 2025-12-11 | Bernstein | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($3.87M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (+23.3%)
- Blackrock Inc.: 8.1% (+10.0%)
- State Street Corpora: 5.6% (+7.0%)
- Price (T.Rowe) Assoc: 4.0% (-27.2%)
- Charles Schwab Inves: 3.5% (+11.4%)

### Key Risks

1. Insider selling cluster: $3.9M in recent transactions.
2. Valuation stretched: PEG 33.5x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 4 raises (avg +10%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +2.3% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 33.55 signals overvaluation risk, limited margin of safety. Forward P/E 13.1x stretched relative to 2% growth. Balance sheet: $1.2B free cash flow. Analyst sentiment positive (4 raises, avg +10%). Insider selling cluster ($3.9M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $58.1B |
| Beta | 0.73 |
| 52W Range | $31.11 - $44.66 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 33.55 |
| Forward P/E | 13.1 |
| Current P/E | 13.4 |
| YoY Growth | 2.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 2.8% to 5.2% (+2.3% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 76th percentile. MRS_5 at 0.3% confirms short-term momentum alignment. AM_20 at 4.9% shows strong absolute momentum above own 20MA. Outperforming sector by 5.3pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -MLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.17% (CS: 76) | Strong |
| RSI_14 | 60.2 | Neutral |
| MACD Histogram | 0.23 | Bullish |
| vs SMA20 | 1.045x | Above |
| vs SMA50 | 1.082x | Above |
| vs SMA200 | 1.090x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $38.90
- **Stop Loss:** $36.68 (5.7% risk)
- **Target:** $42.23 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 450
- **Position Value:** $17,505.00
- **Portfolio %:** 17.51%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-23 (Est: $0.74)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.66 | $0.69 | +4.0% |
| 2025Q2 | $0.73 | $0.74 | +1.7% |
| 2025Q1 | $0.73 | $0.72 | -1.3% |
| 2024Q4 | $0.90 | $0.92 | +2.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*